ASA + high‐dose LMWH vs ASA + low‐dose LMWH or UFH
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
- Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found